ArticleMethods in molecular biology (Clifton, N.J.)2027
Lyophilization Protocol for Long-Term Preservation of Ureolytic Sporosarcina Strains with Biotechnological Applications.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The long-term preservation of biotechnologically relevant bacterial genetic resources is essential, particularly for Sporosarcina spp. strains capable of microbially induced carbonate precipitation (MICP) for toxic metal immobilization. Standard glycerol-based cryopreservation requires an ultra-low-temperature cold chain (-80°C), thereby increasing operational costs and limiting field-scale inoculum transport. To address this bottleneck, lyophilization offers a robust, cost-effective alternative compatible with standard freezing temperatures (-4°C to -20°C). Here, we standardize and validate an optimized lyophilization protocol for Sporosarcina spp. using 20% skim milk as a cryoprotectant. Following a 2-year storage period at -20°C, the lyophilized cells demonstrated high viability and fully retained the urease enzymatic activity required for MICP. These findings demonstrate that this protocol preserves the phenotypic stability and bioremediation potential of Sporosarcina strains without the need for specialized ultra-cold equipment. Consequently, this method provides a highly scalable and viable framework for the formulation of bacterial inocula tailored for in situ field applications.
Indexed as
Identifiers
42911329What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.